Neuronetics, Inc. (STIM) stock
STIMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.25−0.03 (-2.34%)
Close on Nov 18, 2026Market cap $95.25MP/E –Yield –
Neuronetics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Neuronetics's revenue for the twelve months ending Jun 30, 2026 was $155.10M, up 39.6% year over year. For fiscal 2025 it was $149.16M, up 99.2% from the year before. The highest annual figure on record is $149.16M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $149.16M | +99.2% |
| FY2024 | Dec 31, 2024 | $74.89M | +5.0% |
| FY2023 | Dec 31, 2023 | $71.35M | +9.4% |
| FY2022 | Dec 31, 2022 | $65.21M | +17.9% |
| FY2021 | Dec 31, 2021 | $55.31M | +12.3% |
| FY2020 | Dec 31, 2020 | $49.24M | -21.4% |
| FY2019 | Dec 31, 2019 | $62.66M | +18.7% |
| FY2018 | Dec 31, 2018 | $52.78M | +30.5% |
| FY2017 | Dec 31, 2017 | $40.43M | +18.1% |
| FY2016 | Dec 31, 2016 | $34.23M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $41.57M | +9.1% |
| Q1 FY2026 | Mar 31, 2026 | $34.45M | +7.8% |
| Q4 FY2025 | Dec 31, 2025 | $41.78M | +85.7% |
| Q3 FY2025 | Sep 30, 2025 | $37.30M | +101.3% |
| Q2 FY2025 | Jun 30, 2025 | $38.11M | +131.7% |
| Q1 FY2025 | Mar 31, 2025 | $31.98M | +83.6% |
| Q4 FY2024 | Dec 31, 2024 | $22.49M | +10.7% |
| Q3 FY2024 | Sep 30, 2024 | $18.53M | +3.6% |
| Q2 FY2024 | Jun 30, 2024 | $16.45M | -6.6% |
| Q1 FY2024 | Mar 31, 2024 | $17.42M | +12.1% |
| Q4 FY2023 | Dec 31, 2023 | $20.31M | +11.6% |
| Q3 FY2023 | Sep 30, 2023 | $17.88M | +8.4% |
| Q2 FY2023 | Jun 30, 2023 | $17.61M | +7.8% |
| Q1 FY2023 | Mar 31, 2023 | $15.54M | +9.6% |
| Q4 FY2022 | Dec 31, 2022 | $18.20M | +21.1% |
| Q3 FY2022 | Sep 30, 2022 | $16.50M | +19.6% |
| Q2 FY2022 | Jun 30, 2022 | $16.33M | +15.0% |
| Q1 FY2022 | Mar 31, 2022 | $14.18M | +15.4% |
| Q4 FY2021 | Dec 31, 2021 | $15.02M | -3.6% |
| Q3 FY2021 | Sep 30, 2021 | $13.80M | +10.9% |
| Q2 FY2021 | Jun 30, 2021 | $14.20M | +45.8% |
| Q1 FY2021 | Mar 31, 2021 | $12.29M | +7.1% |
| Q4 FY2020 | Dec 31, 2020 | $15.58M | -10.2% |
| Q3 FY2020 | Sep 30, 2020 | $12.45M | -22.2% |
| Q2 FY2020 | Jun 30, 2020 | $9.74M | -41.2% |
| Q1 FY2020 | Mar 31, 2020 | $11.48M | -9.8% |
| Q4 FY2019 | Dec 31, 2019 | $17.36M | +11.0% |
| Q3 FY2019 | Sep 30, 2019 | $16.00M | +16.5% |
| Q2 FY2019 | Jun 30, 2019 | $16.57M | +25.1% |
| Q1 FY2019 | Mar 31, 2019 | $12.73M | +25.4% |
| Q4 FY2018 | Dec 31, 2018 | $15.64M | +29.1% |
| Q3 FY2018 | Sep 30, 2018 | $13.74M | +30.9% |
| Q2 FY2018 | Jun 30, 2018 | $13.25M | +28.6% |
| Q1 FY2018 | Mar 31, 2018 | $10.15M | +34.9% |
| Q4 FY2017 | Dec 31, 2017 | $12.11M | – |
| Q3 FY2017 | Sep 30, 2017 | $10.49M | – |
| Q2 FY2017 | Jun 30, 2017 | $10.31M | – |
| Q1 FY2017 | Mar 31, 2017 | $7.53M | – |
See a number that looks wrong?